POSTED ONDECEMBER 4, 2016NATURAL HEALTH NEWS
By Justin Gardner
In June 2015 we reported on the re-emerging field of using psychedelics to treat mental illness, with psilocybin, in particular, showing great promise for chronic anxiety and depression. Western medicine began realizing its potential in the 1940s, but medical research was stamped out with the War on Drugs.
Now, as the injustice of the drug war is fully exposed, research is again turning to the amazing, natural power of psilocybin. William Richards at Johns Hopkins University has been dosing people with psilocybin for 15 years, and in 2006 published his first study demonstrating positive therapeutic results.
That study provided the impetus for a rapid expansion in psychedelic research. On December 1, results of the first two major clinical trials were published in the Journal of Psychopharmacology – showing yet again psilocybin’s remarkable effect on depression and end-of-life stress.